Tribe Clinical Research in Greenville has announced the launch of a new trial for a drug centered around Alzheimer's ...

"ShiraTronics commences chronic migraine therapy trial" was originally created and published by Medical Device Network, a ...

In a comprehensive Genomic Press Interview, distinguished psychiatrist Professor Peter Falkai suggests promising new ...

By inferring proliferation rates from single-cell genomics, SPRINTER enhances understanding of tumor evolution and identifies ...

Beta-blocker drugs -- commonly used to treat heart and blood pressure issues -- may slow the progression of Huntington's disease (HD), according to a new study.

The St. Joe Company ("St. Joe"), and Margaritaville Holdings (Margaritaville) announce that Latitude Margaritaville Watersound has sold its 2,000th home. Latitude Margaritaville Watersound, an active ...

Almirall, a global pharmaceutical company dedicated to medical dermatology, today announced the launch of “The Hive”, a novel scientific research hub located at its R&D centre in Barcelona, Spain. The ...

The drug rapamycin is being studied for its antiaging and fertility-preserving benefits — and the results seem promising.

Digitalisation and AI in Orthopedic Surgery and Rehabilitation 4.0', and the rapidly evolving subject area, we are pleased to ...

The BHV-7000 study has had a Phase 1 trial by Biohaven Ltd. Fifty-eight patients — most of them middle-aged White men — ...

DIRECTOR General of the National Agency for the Control of AIDS (NACA), Dr Temitope llori has said that HIV infection in ...